Medical Care
Cambridge Prof Claims Synthetic Data Superior in Healthcare AI
2024-11-27
In my previous reports on the difficulties of integrating AI into healthcare, a consistent theme emerged - the essential requirement for researchers to uphold patient confidentiality when dealing with clinical data. While this data is valuable for training AI, it may directly identify an individual or lead to reidentification from anonymized sources. A related issue is that systems trained on datasets lacking patient diversity tend to provide more accurate and detailed results for the majority group but less so for minorities. Clearly, this poses a problem when researching treatments that should be effective for all. As explored in my October 2024 report on AI and medical devices, the same problem extends to technologies predominantly designed, tested, and calibrated within a dominant group of data subjects, potentially leading to less accurate readings for others. Optical sensors are one such tool. My October report examined pulse oximeters commonly used in blood oxygen testing, which gave less accurate readings for people with darker skin tones. During the COVID pandemic, this might have resulted in a higher mortality rate among black and minority ethnic (BAME) patients who were sent home instead of hospitalized due to inaccurate readings.

Overcoming Challenges and Ensuring Data Safety

Using AI-Improved Data and Synthetic Data

Professor Mihaela van der Schaar, John Humphrey Plummer Professor of Machine Learning, AI, and Medicine at the University of Cambridge and Director of the Cambridge Centre for AI in Medicine, believes that AI can enhance the quality of data. Whether it's electronic health record data, data in bio banks, or clinical registries, high-quality data is crucial for AI and epidemiology. Medical data contains various errors such as complex real-world data, multimodal data that needs aggregation, and data that may be unfair, noisy, or missing informative elements. In the case of rare diseases, data may be limited or private and cannot be shared. Data also changes over time due to changing practices, demographics, or emerging diseases like COVID. With AI, we can improve data quality at every stage of model design. This includes imputing missing data, reducing noise, and dealing with "heart" examples. We can harmonize different types of datasets from various clinical trials and between them and electronic health records. At the training model stage, we can divide data into subgroups for more robust training or data-informed model selection. We can also test models using new data-centric approaches and address data shift and drift.

Addressing the Limitations of Synthetic Data

The broad area of synthetic data, along with the emerging challenge of AI training other AIs with AI-generated data, alarms some commentators. Last year, researcher Jathan Sadowski coined the term 'Habsburg AI' to describe this problem. Just as photocopying a photocopy leads to a loss of the original image, synthetic content may overwhelm human-made content online. Generative AI's 'hallucinations' also pose a problem as humans relying on AI for information may find themselves in a world of untrustworthy data. My recent report on the problem with pulse oximeters shows that synthetic data may have flaws. During the COVID pandemic, it was reported that BAME patients were at higher risk due to inaccurate readings from pulse oximeters tested mainly on white skin tones. The British government has acknowledged this problem, but no adjustments have been made. Synthetic data may amplify a majority view and overlook significant anomalies in human data. Professor van der Schaar rejects these comparisons, stating that synthetic data is a powerful creation that can improve data quality and simulate forward-moving scenarios. However, there is good and bad synthetic data, and human researchers need to be able to distinguish between them.

The Role of Clinicians in AI-Enabled Ecosystems

We hope to build an AI-empowered clinical ecosystem with various analytics. These analytics are designed and thought about by clinicians who know their needs and how to test systems. As research progresses, we need to be cautious about the emerging world of AI. By 2026, most online content is expected to be synthetic. AIs will be trained by other AIs using AI-generated data, potentially leading to a Habsburg-style future where technology refers more to itself than to humans. At this point, we need humans who can step outside the system and identify its flaws. In the meantime, diginomica will continue to report on these issues as we are only human.
GE HealthCare Launches New Mammography System for Workflow Boost
2024-11-27
The Pristina Via mammography system by GE HealthCare is making significant waves in the field of breast care. It aims to enhance technologist workflow and provide personalized care to patients. This system offers a range of advanced features that set it apart from other available mammography systems.

Unlock the Potential of Pristina Via for Enhanced Breast Care

Zero-Click Acquisition Functionality

The Pristina Via system boasts a zero-click acquisition functionality, which enables rapid and seamless procedures. This means that technologists can start the imaging process with just a single action, saving valuable time. It eliminates the need for multiple clicks and complex settings, allowing for a more efficient workflow. For example, instead of spending time adjusting settings and clicking through different menus, technologists can focus on positioning the patient and obtaining high-quality images. This not only speeds up the process but also reduces the potential for errors.

Moreover, the zero-click acquisition functionality is designed to be intuitive and user-friendly. Technologists can quickly adapt to this feature, even if they are not familiar with the system. This helps to improve their productivity and confidence in using the Pristina Via mammography system.

No Wait Time Between Exposures

Another notable feature of the Pristina Via system is the absence of wait time between exposures. This allows technologists to work at their preferred pace, without being limited by long waiting periods. They can take multiple images in quick succession, ensuring that they capture all the necessary information.

For instance, in a busy screening environment, where time is of the essence, the no wait time between exposures can make a significant difference. Technologists can move from one patient to another without any delays, maximizing their efficiency and throughput. This not only benefits the patients but also helps to reduce the overall waiting time for imaging services.

Fast Digital Breast Tomosynthesis (DBT) Image-to-Image Cycle Time

The digital breast tomosynthesis (DBT) image-to-image cycle time of the Pristina Via system is reportedly up to twice as fast compared to other available mammography systems. This means that technologists can obtain detailed 3D images of the breast in a shorter period, allowing for more accurate diagnoses.

With faster DBT image-to-image cycle times, technologists can quickly assess the breast tissue and detect any abnormalities. This can lead to earlier detection of breast cancer and improved patient outcomes. Additionally, the faster imaging process also reduces the radiation dose to the patient, making it a more safe and comfortable option.

Vendor-Neutral Prior Image Comparison

The Pristina Via system offers vendor-neutral prior image comparison, which helps to decrease the analyzing time spent on earlier examinations. By comparing current images with previous ones, technologists can easily identify any changes or abnormalities, saving time and improving the accuracy of diagnoses.

For example, if a patient has had previous mammograms or breast imaging studies, the vendor-neutral prior image comparison feature allows technologists to quickly access and compare these images. This can be particularly useful in detecting subtle changes over time and monitoring the progression of any existing conditions.

Scalable Platform with Full Backward Compatibility

The Pristina Via system has a scalable platform with full backward compatibility, allowing imaging centres to access the latest capabilities. This means that as technology advances, imaging centres can easily upgrade their systems without having to replace their existing equipment.

The full backward compatibility ensures that technologists can continue to use their familiar workflows and software while also benefiting from the latest features and improvements. This provides a seamless transition for imaging centres and helps to minimize disruptions to their daily operations.

GE HealthCare Women’s Health and X-ray CEO and president Jyoti Gupta emphasized the company’s commitment to addressing customer needs: “At GE HealthCare, we are dedicated to delivering solutions that enhance the experience for both patients and healthcare professionals. Pristina Via represents a significant evolution in our patient-focused Senographe Pristina platform, which was designed by women for women.”GE HealthCare global mammography general manager and vice-president Pooja Pathak highlighted the system’s design during the intensive collaboration with end users: “During our design phase, we heard that the technologist’s workday can feel like a race against the clock. Pristina Via is our answer to this challenge. The system’s advanced features were engineered to automate processes and allow our users to give patients the attentive, quality care they deserve.”During this month, the Food and Drug Administration (FDA) granted 510(k) clearance for the company’s SIGNA MAGNUS MRI scanner, further demonstrating GE HealthCare’s leadership in medical imaging.Sign up for our daily news round-up to stay updated on the latest advancements in breast care and medical imaging. Give your business an edge with our leading industry insights.
See More
AWS & Philips Team Up to Migrate Health Systems to the Cloud
2024-11-27
Health technology company Royal Philips and Amazon Web Services (AWS) have taken a significant step forward in their partnership. By expanding their strategic collaboration, they are now offering Philips' integrated diagnostics portfolio in the cloud. This move is set to revolutionize the healthcare industry and bring numerous benefits to healthcare providers and patients alike.

Unlock the Potential of Cloud-Based Healthcare with Philips and AWS

North America and Latin America: A Successful Transition

Already, 150 sites across North America and Latin America have successfully transitioned to Philips HealthSuite Imaging on AWS. This achievement showcases the effectiveness and reliability of their collaboration. Healthcare providers in these regions are experiencing enhanced workflow efficiency and more valuable time to focus on patient care.The seamless migration of these health systems to the cloud has paved the way for further expansion. Now, the focus is on accelerating this migration to Europe and exploring new opportunities in the healthcare landscape.

Integrated Diagnostics Portfolio: Uniting Patient Data

Philips' integrated diagnostics portfolio is a game-changer. It encompasses radiology, digital pathology, cardiology, and artificial intelligence (AI) visualization solutions. This unified view of patient data from different diagnostic sources allows healthcare providers to make more informed decisions and provide better care.With remote access to diagnostic, reporting, and workflow orchestration tools, healthcare professionals can now collaborate more effectively and provide timely care regardless of their physical location.

Generative AI: Automating Routine Tasks and Optimizing Workflows

Philips is at the forefront of using generative AI to automate routine tasks and optimize workflows. For example, clinicians can use conversational language to create and revise reports that support diagnosis and quality of care. This not only saves time but also improves the accuracy and efficiency of healthcare processes.By combining Philips' healthcare informatics portfolio with AWS generative AI capabilities, clinicians have access to imaging insights like never before. They can deliver more effective and efficient care to patients anywhere, anytime, with the highest level of security and privacy.

AWS and GE HealthCare: Teaming Up for Better Diagnoses

In another significant collaboration, AWS and GE HealthCare have joined forces to help clinicians improve diagnoses using AI. GE HealthCare will utilize AWS as its cloud provider and leverage the company's healthcare and generative AI services.This partnership aims to increase diagnostic and screening accuracy, improve patient outcomes, and provide greater access and equitable care. It showcases the power of collaboration in driving innovation in the healthcare industry.

AWS HealthScribe: Saving Time for Clinicians

In July 2023, AWS debuted AWS HealthScribe, a tool that uses speech recognition and generative AI to generate clinical documentation. This tool is a game-changer for clinicians, as it helps them save time summarizing patient visits.Automatically creating transcripts, extracting details such as medical terms and medications, and creating summaries from doctor-patient discussions, AWS HealthScribe streamlines the documentation process and allows clinicians to focus more on patient care.The collaboration between Royal Philips and AWS, along with their partnerships with other industry leaders, is shaping the future of healthcare. By leveraging the power of cloud computing and generative AI, they are paving the way for more efficient, accurate, and accessible healthcare services.
See More